Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 3/20 | 0.41 |
| ▸ | MEN1 | O00255 | 2/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.41 |
| ▸ | ATM | Q13315 | 2/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | PKM | P14618 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | FTO | Q9C0B1 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22627490 | 0.85 | L3MBTL1 (0.44) | L3MBTL1MEN1KMT2AATMNPC1 | |
| SCHEMBL19731905 | 0.82 | MEN1 (0.44) | L3MBTL1MEN1KMT2AATMNPC1 | |
| SCHEMBL18830876 | 0.73 | KDM4E (0.43) | L3MBTL1MEN1KMT2AKDM4EALDH1A1 | |
| SCHEMBL21841136 | 0.73 | L3MBTL1 (0.56) | L3MBTL1MEN1KMT2ANPC1HSP90AA1 | |
| SCHEMBL22432413 | 0.72 | ELANE (0.33) | — | |
| SCHEMBL19413657 | 0.72 | LMNA (0.51) | L3MBTL1MEN1KMT2AHSP90AA1KDM4E | |
| SCHEMBL24201041 | 0.71 | L3MBTL1 (0.49) | L3MBTL1NPC1HSP90AA1KDM4EALDH1A1 | |
| SCHEMBL17792923 | 0.71 | L3MBTL1 (0.44) | L3MBTL1NPC1HSP90AA1KDM4EALDH1A1 | |
| SCHEMBL23183282 | 0.70 | L3MBTL1 (0.39) | L3MBTL1MEN1KMT2AATMNPC1 | |
| SCHEMBL14511529 | 0.69 | NFE2L2 (0.34) | L3MBTL1MEN1KMT2AATMNPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20170362241-A1 | 1-FUNCTIONALIZED DIBENZOFURANS AND DIBENZOTHIOPHENES FOR ORGANIC LIGHT EMITTING DIODES (OLEDS) | IDEMITSU KOSAN CO., LTD. (JP) | 2017-12-21 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170362241-A1 | 1-FUNCTIONALIZED DIBENZOFURANS AND DIBENZOTHIOPHENES FOR ORGANIC LIGHT EMITTING DIODES (OLEDS) | OCIAD1, OCIAD2, DDT | L3MBTL1 1179/4885MEN1 3404/4885KMT2A 4080/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.